Sernova (FRA:PSH) Dividend Payout Ratio : 0.00 (As of Jan. 2024)

View and export this data going back to 2014. Start your Free Trial

What is Sernova Dividend Payout Ratio?

Sernova's dividend payout ratio for the months ended in Jan. 2024 was 0.00.

The historical rank and industry rank for Sernova's Dividend Payout Ratio or its related term are showing as below:

FRA:PSH's Dividend Payout Ratio is not ranked ^*
in the Biotechnology industry.
Industry Median: 0.415
* Ranked among companies with meaningful Dividend Payout Ratio only.

As of today (2024-04-26), the Dividend Yield % of Sernova is 0.00%.

Sernova's Dividends per Share for the months ended in Jan. 2024 was €0.00.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.

Sernova Dividend Payout Ratio Historical Data

The historical data trend for Sernova's Dividend Payout Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sernova Dividend Payout Ratio Chart

Sernova Annual Data

Trend

Oct14

Oct15

Oct16

Oct17

Oct18

Oct19

Oct20

Oct21

Oct22

Oct23

Dividend Payout Ratio

Get a 7-Day Free Trial

Sernova Quarterly Data
	Apr19	Jul19	Oct19	Jan20	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24
Dividend Payout Ratio	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Sernova's Dividend Payout Ratio

For the Biotechnology subindustry, Sernova's Dividend Payout Ratio, along with its competitors' market caps and Dividend Payout Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Sernova's Dividend Payout Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Sernova's Dividend Payout Ratio distribution charts can be found below:

* The bar in red indicates where Sernova's Dividend Payout Ratio falls into.

Sernova Dividend Payout Ratio Calculation

Dividend payout ratio measures the percentage of the company's earnings paid out as dividends.

Sernova's Dividend Payout Ratio for the fiscal year that ended in Oct. 2023 is calculated as

Dividend Payout Ratio	=	Dividends per Share (A: Oct. 2023 )	/	EPS without NRI (A: Oct. 2023 )
	=	0	/	-0.09
	=	N/A

Sernova's Dividend Payout Ratio for the quarter that ended in Jan. 2024 is calculated as

Dividend Payout Ratio	=	Dividends per Share (Q: Jan. 2024 )	/	EPS without NRI (Q: Jan. 2024 )
	=	0	/	-0.021
	=	N/A

Sernova (FRA:PSH) Dividend Payout Ratio Explanation

In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

Sernova Dividend Payout Ratio Related Terms

Thank you for viewing the detailed overview of Sernova's Dividend Payout Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.

Sernova (FRA:PSH) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Sernova Corp (FRA:PSH) » Definitions » Dividend Payout Ratio

Comparable Companies

Traded in Other Exchanges

SEOVF:USA PSH:Germany SVA:Canada

Address

700 Collip Circle, The Stiller Centre, Suite 114, London, ON, CAN, N6G 4X8

Website

https://www.sernova.com

Sernova Corp is a clinical-stage company developing products for the treatment of chronic debilitating diseases. The company is engaged in the research and development of its proprietary Cell Pouch and associated technologies including immune-protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device designed to create a vascularized tissue environment for the transplantation and engraftment of therapeutic cells, which then release proteins and or hormones for the long-term treatment of multiple serious, chronic diseases such as diabetes, hemophilia, and thyroid disease.